Hostname: page-component-89b8bd64d-b5k59 Total loading time: 0 Render date: 2026-05-11T05:36:57.746Z Has data issue: false hasContentIssue false
  • English
  • Français

Human T-Cell Lymphotropic Virus-Type I

Published online by Cambridge University Press:  21 June 2016

Julie Larkin ,
John T. Sinnott IV ,
Joshua Weiss  and
Douglas A. Holt
Julie Larkin
Affiliation:
Division of Infectious and Tropical Diseases, Department of Internal Medicine, University of South Florida College of Medicine, ‘Tampa, Florida
John T. Sinnott IV*
Affiliation:
Department of Epidemiology, The Tampa General Hospital, ‘Tampa, Florida
Joshua Weiss
Affiliation:
Division of Infectious and Tropical Diseases, Department of Internal Medicine, University of South Florida College of Medicine, ‘Tampa, Florida
Douglas A. Holt
Affiliation:
Division of Infectious and Tropical Diseases, Department of Internal Medicine, University of South Florida College of Medicine, ‘Tampa, Florida
*
Director of Epidemiology, The Tampa General Hospital, PO Box 1289, Tampa, FL 33601
Get access Rights & Permissions [Opens in a new window]

Extract

Human T-cell lymphotropic virus type-1 (HTLV-I) is a recently recognized retrovirus identified as the cause of adult T-cell leukemia-lymphoma (ATLL) and HTLV-I-associated myelopathy (TSPI HAM). HTLV-I, a member of the Retroviridae family of viruses, was first described in 1980 after the isolation of the virus from a patient with a T-cell lymphoma. These pathogenic retroviruses are typically divided into the Oncovirinae and Lentivirinae. The oncovirus group, including HTLV-I, HTLV-II and bovine leukemia virus (BLV), is generally associated with tumors. The lentiviruses are associated with immune deficiency and/or neurologic disease, and include agents such as the visna virus of sheep and the human immunodeficiency virus type-1 and -2 HIV-1 and HIV-2).

Information

Type
Special Sections
Information
Infection Control & Hospital Epidemiology , Volume 11 , Issue 6 , June 1990 , pp. 314 - 318
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1990 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1. Poiesz, BJ, Ruscetti, FW, Gazdar, AF, Bunn, PA, Minna, JD, Gallo, RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U.S.A. 1981;77:7415–7419.Google Scholar
2. Jawetz, E, Melnick, JL, Adelberg, EA. Review of Medical Microbiology. 17th ed. Norwalk, Conn/Los Altos, Ca: Appleton and Lange: 1987.Google Scholar
3. Anderson, D. Epstein, J, Pierik, L, et al. Licensure and screening tests for antibody to human T-lymphotopic virus type-l. MMWR. 1988;37:736–747.Google Scholar
4. Kwok, S, Kellogg, D, Ehrlich, G, Poiesz, B, Bhagauati, S, Snisky, JJ. Characterization of a sequence of human T-cell leukemia virus from a patient with chronic progressive myelopathy. J Infect Dis. 1988;158:1193–1197.Google Scholar
5. Bangham, CR, Daenke, S, Phillips, R, Cruickshank, JK, Bell, JI. Enzymatic amplification of exogenous and endogenous retroviral sequences from DNA of patients with tropical spastic paraparesis. EMBO J. 1988;7:4179–4184.Google Scholar
6. Nakamura, T Tsujihata, M, Shirabe, S, Matsuo, H. Ueki Yt Nagataki S. Characterization of HTLV-I in a T-cell line established from a patient with myelopathy. Arch Neurol. 1989;46:35–37.Google Scholar
7. Hinuma, Y, Komoda, H. Chosa, T. et al. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer. 1982;29:631–635.Google Scholar
8. Blattner, WA, Kalyanaraman, VS. Robert-Guroff, M, et al. The human type-C retrovirus, HTLV, in blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer. 1983;30:257–264.Google Scholar
9. Gibbs, WN, Loiters, WS, Campbell, M, et al. Non-Hodgkm's lymphoma in Jamaica and its relation to adult T-cell leukemia-lymphoma. Ann Intern Med. 1987;106:361–368.Google Scholar
10. Fleming, AF, Majarajan, R, Abraham, M. et al. Antibodies to HTLV-I in Nigeria blood-donors, their relatives and patients with leukemias lymphomas and other diseases. Int J Cancer. 1986;38:809–813.Google Scholar
11. Cartes, E, Detels, R, Aboulafia, D, et al. HIV-1. HIV-2. and HTLV-1 infection in high-risk groups in Brazil. N Engl J Med. 1989;320:953–958.Google Scholar
12. Cartier-Rovirosa, L. Mora, C, Araya, F, et al. HTLV-I positive spastic paraparesis in a temperate zone. Lancet. 1989;1:556–557.Google Scholar
13. Greaves, MF, Verbi, W. Tilley, R, et al. Human T-cell leukemia virus (HTLV)m the United Kingdom. Int J Cancer. 1984;33:795–806 Google Scholar
14. Manzari, V, Grandilon, A, Barillari, G. et al. HTLV-I is endemicin. southern Italy: detection of the first infectious cluster in a white population. Int J Cancer. 1985;36:557–559.Google Scholar
15. Gout, O, Gessain, A, Bolgert, FT et al. Chronic myelopathies associated with human T-lymphotropic virus type-1. A clinical, serologic. and immunovirologic study of ten patients in France. Arch Neurol. 1989;46:255–260.Google Scholar
16. Levine, PH, Jaffe, E, Manns, A. Murphy, EL. Clark, J, Blattner, WA. Human T-cell lymphotropic virus type-1 and adult T-cell leukemia lymphoma outside Japan and the Caribbean basin. Yale J Biol Med. 1988;61:215–222.Google Scholar
17. Gallo, R, Shsks, A, Wang-Stall, F. Origin of human T-cell leukemia lymphoma virus. Lancet. 1983;2:962–963.Google Scholar
18. lshida, T, Hinuma, Y. Origin of Japanese HTLV-I. Nature. 1986;322:504.Google Scholar
19. lshida, T, Yamamoto, K. Omoto, K. A seroepidemiologic survey of HTLV-I in the Philippines Ini J Epidemiol. 1988;17:625–628.Google Scholar
20. Saxton, EH. Lee, H, Swanson, P, et al. Detection of human T-cell leukemia/lymphoma virus type-1 in a transfusion recipient with chronic myelopathy. Neurology. 1989;39:841–844.Google Scholar
21. Cohen, N, Munoz, A. Reitz, BA, et al. Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery. N Engl J Med. 1989;320:1172–1176.Google Scholar
22. Barnes, D. HTLV-I: to test or not to test. Science. 1988;242:372–373.Google Scholar
23. Gore, I. Decker, WD, Snyder, TL. Isolation andmolecular characterization of HTLV-I and HTLV-II from the peripheral blood of intravenous drug users. J Cell Biochem. 1989;13B:272.Google Scholar
24. Robert-Guroff, M, Weiss, SH. Giron, JA. Prevalence of antibodies to HTLV-I. II, and Ill in intravenous drug abusers from an AIDS endemic region. JAMA. 1986;255:3133–3137.Google Scholar
25. Murphy, E. Figueroa, JP. Gibbs, W. et al. Sexual transmission of human T-lymphotropic virus type-1 (HTLV-I). Ann Intern Med. 1989;111:555–560.Google Scholar
26. Williams, A, Fang, C, Slamon, D, et al. Seroprevalence and epidemiologic correlates of HTLV-I infection in U.S. blood donors. Science. 1988;40:643–646.Google Scholar
27. Bartholomew, C, Saxinger, W. Clark, J, et al. Transmission of HTLV-I and HIV among homosexual men in Trinidad. JAMA. 1987;257:2604–2608.Google Scholar
28. Nakamura, T. Matsuo, H. Shirabe, S, et al. Familial clusters in human T-cell lymphotropic virus type-l-associated myelopathy. Arch Neurol 1989;46:250–251.Google Scholar
29. Sugiyama, H, Doi, H, Yamaguchi, K. Tsuji, Y, Miyamoto, T, Hino, S. Significance of postnatal mother-to-child transmission of human virus type-1 on the development of adult T-cell leukemia/lymphoma. J Med Virol. 1986;20:253–260.Google Scholar
30. Miller, G, Pegram, ST Kirkwood, B. et al. Ethnic composition, age and sex, together with location and standard of housing as determinants of HTLV-I infection in an urban Trinidadian community. Int J Cancer. 1986;38:801–808.Google Scholar
31. Murphy, E, Cahsher, C. Gifueroa, J, Gibbs, WN. Blattner WA HTLV-I infection and arthropod vectors. N Engl J Meo. 1989;320:1146.Google Scholar
32. Lee, S. Mastushita, K, Machida, J. et al. Human T-cell leukemia virus type-1 infection in hemodialysis patients. Cancer. 1987;60:1474–1478.Google Scholar
33. Sato, Y, Shroma, Y. Concurrent Infections with Strongyloides and T-cell leukemia virus and their possible effects on immune responses of host. Clin Immunol Immunopathol. 1989;52:214–224.Google Scholar
34. Motoharus, S, Hattori, S. Hirayama, Y, et al. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemic cell DNA. Pro Natl Acad Sci U.S.A. 1983;80:3618–3622.Google Scholar
35. Seike, M. Eddy, R, Shows, TB, Yoshida, M. Nonspecific integration of the HTLV provirus genome into adult T-cell leukemia. Nature. 1984;309:640–642.Google Scholar
36. Cann, AJ. Rosenblatt, J. Wachsman, W, Shah, NP, Chen, IS. Identiflca-of the gene responsible for human T-cell leukemia virus transcriptional regulation. Nature. 1985;318:571–574.Google Scholar
37. Poteat, HT, Kadison, P, McGuire, K, et al. Response of human T-cell leukemia virus type I long terminal repeat to cyclic AMP. J Virol. 1989;63:1604–1611.Google Scholar
38. Nagata, K, Ohtani, K, Nakamura, M, Sugamura, K. Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40 tax protein in the human T-cell line, Jurkat. J Virol. 1989;63:3220–3226.Google Scholar
39. Kronke, M. Leonard, WJ, Depper, JM, Greene, WC. Deregulation of interleukin-2 receptor gene expression on HTLV-I induced adult T-cell leukemia. Science. 1985:228:1215–1217.Google Scholar
40. Tokudome, S, Tokunuga, O, Shimamato, Y, et al. Incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic type I virus carriers in Saga, Japan. Cancer Res. 1989:49:226–228.Google Scholar
41. Kondo, T. Kono, H. Miyamoto, N, et al. Age-and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int J Cancer. 1989;43:1061–1064.Google Scholar
42. Kinoshita, K. Amagasaki, T, Ikeda, S, et al. Preleukemic state of adult T-cell leukemia: abnormal T lymphocytosis induced by human adult T-cell leukemia-lymphoma virus. Blood. 1985;66:120–127.Google Scholar
43. Yamaguchi, K. Nishimura, H. Kohrogi, H, et al. A proposal for smoldering adult T-cell leukemia: a clinicopathologic study of five cases. Blood. 1983;62:758–766.Google Scholar
44. Kawano, F. Yamaguchi, K, Nishimura, H, Tsuda, H, Takatsuki, K. Variation in the clinical courses of adult T-cell leukemia. Cancer. 1985;55:851–856.Google Scholar
45. Vukelja, SJ. Weiss, RB, Perry, DJ. Longo, DL. Eosinophilia associated with adult T-cell leukemia/lymphoma. Cancer. 1988;62:1527–1530.Google Scholar
46. Scully, R, Mark, E, McNeedy, W. et al. Case records of the Massachusetts General Hospital. N Engl J Med. 1989;321:663–675.Google Scholar
47. Blayney, DW, Jaffe, ES. Fisher, RI. et al. The human T-cell leukemia/lymphoma virus, lymphoma, lytic bone lesions, and hypercalcemia. Ann Intern Med. 1983;98:144–151.Google Scholar
48. Yoshika, R, Yamaguchi, K. Yoshinaga, T. et al. Pulmonary complications in patients with adult T-cell leukemia. Cancer. 1985;55:249l–2494.Google Scholar
49. Fbkumoto, S, Matsumoto, T, Ikeda, K. et al. Clinical evaluation of calcium metabolism in adult T-cell leukemia/lymphoma. Arch Intern Med. 1988;148:921–925.Google Scholar
50. Kwok, S, Ehrlich, G, Poiesz, B, Kalish, R. Snisky, JJ. Enzymatic amplification of HTLV-I proviral sequences from peripheral blood mononuclear cells and infected tissues. Blood. 1989;72:1117–1123.Google Scholar
51. Shimoyama, M, Ota, K. Kikuchi, M, et al. Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia. J Clin Oncol. 1988:6:1088–1097.Google Scholar
52. Tamura, K, Makino, S. Araki, Y, Imamura, T, Seita, M. Recombinant interferon beta and gamma in the treatment of adult T-cell leukemia. Cancer. 1987;59:1059–1062.Google Scholar
53. Waldmann, TA, Goldman, CK. Bongiovanni, KF, et al. Therapy of patients with human T-cell lymphotropic virus-I-induced adult T-cell leukemia with antitat, a monoclonal antibody to the receptor for interleukin-2. Blood. 1988;72:1805–1816.Google Scholar
54. Gessain, A. Barin, F, Vernant, JC, et al. Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet. 1985;2:407–409.Google Scholar
55. Osarne, M, Usuku, K, Izumo, S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986:1:1031–1032.Google Scholar
56. Roman, G, Osarne, M. Identity of HTLV-I associated tropical spastic paraparesis and HTLV-I associated myelopathy. Lancet. 1988;1:651.Google Scholar
57. Shibasaki, H. Endo, C, Kuroda, Y, et al. Clinical picture of HTLV-I associated myelopathy. J Neurol Sci. 1988;87:15–24.Google Scholar
58. Grimaldi, LM, Roos, RP, Devare, SG. et al. HTLV-L associated myelopathy: oligoclonal immunoglobulin G bands contain anti-HTLV-I p24 antibody. Arm Neurol. 1988;24:727–731.Google Scholar
59. Kira, J. Minato, S. Itoyama, Y, Goto, I, Kato, M, Hasuo, K. Leukoenceph-alopathy in HTLV-l-associated myelopathy: MRI and EEG data. J Neurol Sci. 1988;87:221–232.Google Scholar
60. Yonenaga, Y, Arimura, K. Suehara, M, Arimura, YT Osarne, M. Electro-encephalographic abnormalities in human T-cell lymphotropic virus type I-associated myelopathy. Arch Neurol. 1989;46:513–516.Google Scholar
61. Kakigi, R, Shibasaki, H, Kuroda, YT et al. Multimodality evoked potentials in HTLV-I associated myelopathy. J Neurol, Neuronu rg Psychiatry. 1988:51:1094–1096.Google Scholar
62. Ijichi, S, Eiraku, N, Osarne, M, et al. In vitro modulation of lymphocyte proliferation by predunisolone and interferon-alpha in patients with HTLV-I associated myelopathy (HAM). J Neurol. 1989;23:175–178.Google Scholar
63. Matsuo, H, Nakamura, T. Shibayama, K, Nagasato, K, Tsujihata, M, Nagataki, S. Long-term followup of immunomodulation in treatment of HTLV-I-associated myelopathy. Lancet. 1989;1:790.Google Scholar
64. Iwasaki, Y, Kinoshita, M, Ikeda, K. Takamiya, K. Human T-lymphotropic virus type I-associated myelopathy presenting as spinocerebellar syndrome. Ann Neurol. 1989:25:419–420.Google Scholar
65. Kano, M. Mitsuhata, Y, Kishida, S, et al. Shy-Drager Syndrome and human T-cell lymphotropic virus type-1 infection. Ann Neurol. 1989;25:420–421.Google Scholar
66. Araga, S, Takahashi, K, Ooi S: Subacute meningoencephalitis associated with human T-lymphotropic virus type-1 (HTLV-I) Report of a case. Acta Neurol 1989:79:361–365.Google Scholar
67. Reddy, EP, Sandburg-Wollheim, M, Mettus, Ry. Ray, PE. DeFreitas, E, Koprowski, H. Amplification and molecular cloning of HTLV-I sequences from DNA of multiple sclerosis patients. Science. 1989;243:529–533.Google Scholar
68. Gebarski, SS, Gabrielsen, TO, Gilman, S, Knake, JE. Latack, JT, Aisen, AM. The initial diagnosis of multiple sclerosis: clinical impact of magnetic resonance imaging. Ann Neurol. 1985:17:469–474.Google Scholar